These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 39033140)

  • 1. Copy number losses of oncogenes and gains of tumor suppressor genes generate common driver mutations.
    Besedina E; Supek F
    Nat Commun; 2024 Jul; 15(1):6139. PubMed ID: 39033140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.
    Wang G; Anastassiou D
    Sci Rep; 2020 Oct; 10(1):17199. PubMed ID: 33057153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis.
    Thiesen HJ; Steinbeck F; Maruschke M; Koczan D; Ziems B; Hakenberg OW
    PLoS One; 2017; 12(5):e0176659. PubMed ID: 28486536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
    Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
    J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
    Franch-Expósito S; Bassaganyas L; Vila-Casadesús M; Hernández-Illán E; Esteban-Fabró R; Díaz-Gay M; Lozano JJ; Castells A; Llovet JM; Castellví-Bel S; Camps J
    Elife; 2020 Jan; 9():. PubMed ID: 31939734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide identification of significant aberrations in cancer genome.
    Yuan X; Yu G; Hou X; Shih IeM; Clarke R; Zhang J; Hoffman EP; Wang RR; Zhang Z; Wang Y
    BMC Genomics; 2012 Jul; 13():342. PubMed ID: 22839576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering.
    Van den Eynden J; Fierro AC; Verbeke LP; Marchal K
    BMC Bioinformatics; 2015 Apr; 16():125. PubMed ID: 25903787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.
    Koboldt DC; Zhang Q; Larson DE; Shen D; McLellan MD; Lin L; Miller CA; Mardis ER; Ding L; Wilson RK
    Genome Res; 2012 Mar; 22(3):568-76. PubMed ID: 22300766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of constrained cancer driver genes based on mutation timing.
    Sakoparnig T; Fried P; Beerenwinkel N
    PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific genomic regions are differentially affected by copy number alterations across distinct cancer types, in aggregated cytogenetic data.
    Kumar N; Cai H; von Mering C; Baudis M
    PLoS One; 2012; 7(8):e43689. PubMed ID: 22937079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-exome sequencing reveals potential germline and somatic mutations in 60 malignant ovarian germ cell tumors†.
    Chen J; Li Y; Wu J; Liu Y; Kang S
    Biol Reprod; 2021 Jul; 105(1):164-178. PubMed ID: 33739378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
    Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
    PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures.
    Graham NA; Minasyan A; Lomova A; Cass A; Balanis NG; Friedman M; Chan S; Zhao S; Delgado A; Go J; Beck L; Hurtz C; Ng C; Qiao R; Ten Hoeve J; Palaskas N; Wu H; Müschen M; Multani AS; Port E; Larson SM; Schultz N; Braas D; Christofk HR; Mellinghoff IK; Graeber TG
    Mol Syst Biol; 2017 Feb; 13(2):914. PubMed ID: 28202506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the genetic landscape during the malignization of high grade squamous intraepithelial lesion into cervical cancer.
    Litviakov NV; Ibragimova MK; Tsyganov MM; Shpileva OV; Churuksaeva ON; Kolomiets LA
    Curr Probl Cancer; 2020 Oct; 44(5):100567. PubMed ID: 32201051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher order genetic interactions switch cancer genes from two-hit to one-hit drivers.
    Park S; Supek F; Lehner B
    Nat Commun; 2021 Dec; 12(1):7051. PubMed ID: 34862370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CaSNP: a database for interrogating copy number alterations of cancer genome from SNP array data.
    Cao Q; Zhou M; Wang X; Meyer CA; Zhang Y; Chen Z; Li C; Liu XS
    Nucleic Acids Res; 2011 Jan; 39(Database issue):D968-74. PubMed ID: 20972221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidate targets of copy number deletion events across 17 cancer types.
    Huang Q; Baudis M
    Front Genet; 2022; 13():1017657. PubMed ID: 36726722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction-Based Feature Selection for Uncovering Cancer Driver Genes Through Copy Number-Driven Expression Level.
    Park H; Niida A; Imoto S; Miyano S
    J Comput Biol; 2017 Feb; 24(2):138-152. PubMed ID: 27759426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.
    Bányai L; Trexler M; Kerekes K; Csuka O; Patthy L
    Elife; 2021 Jan; 10():. PubMed ID: 33427197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequencing approaches in cancer treatment.
    Sekar D; Thirugnanasambantham K; Hairul Islam VI; Saravanan S
    Cell Prolif; 2014 Oct; 47(5):391-5. PubMed ID: 25131793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.